Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line

Journal of Steroid Biochemistry and Molecular Biology

Volumn 123, Issue 1-2, 2011, Pages 85-89

  Somjen, D ^a   Katzburg, S ^a   Grafi Cohen, M ^a   Knoll, E ^a   Sharon, O ^a   Posner, G H ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

HETE; Lipoxygenase; ROS; SaOS2; Vitamin D less calcemic analogs; Vitamin D metabolites

Indexed keywords

ACETYLCYSTEINE; BAICALEIN; CREATINE KINASE; DIPHENYLIODONIUM SALT; LIPOXYGENASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; VITAMIN D DERIVATIVE;

ARTICLE; BONE CELL; BONE GROWTH; CELL PROLIFERATION; CREATINE KINASE BLOOD LEVEL; DNA SYNTHESIS; ENERGY METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID OXIDATION; OSTEOBLAST; OXIDATIVE STRESS; PROTEIN EXPRESSION;

BONE AND BONES; CELL LINE; CELL PROLIFERATION; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LIPOXYGENASE; NADPH OXIDASE; ONIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; VITAMIN D;

EID: 78650535640     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.11.010     Document Type: Article

References (22)

1. Q. Shen, and S. Christakos The vitamin D receptor, RUNX2 and the notch-signalling pathway cooperate in the transcriptional regulation of osteopontin J. Biol. Chem. 280 2005 40589 40598
2. 2D3 enhancement of mouse secreted phosphor-protein 1 (SPP-1 or osteopontin) gene expression Proc. Natl. Acad. Sci. U.S.A. 87 1990 9995 9999
3. 2D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases J. Biol. Chem. 280 2005 14130 14137
4. H. Tanaka, and Y. Seino Vitamin D metabolites and bone D. Feldman, F.H. Glorieux, J.W. Pike, Vitamin D 1997 Academic Press San-Diego 305 311
5. M.F. Holick The vitamin D epidemic and its health consequences J. Nutr. 135 2005 2739S 2748S
6. J.C. Gallagher Drug therapy of osteoporosis: calcium, estrogen and vitamin D B.L. Riggs, L.J. Melton III Osteoporosis: Etiology, Diagnosis and Management vol. 1 1988 Raven Press New York 389 401
7. M.F. Holick Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease Am. J. Clin. Nutr. 80 Suppl. 2004 1678S 1688S
8. 3: synthesis and preliminary biological evaluation Bioorg. Med. Chem. 13 2005 2959 2966 (Pubitemid 40387503)
9. D. Somjen, S. Katzburg, E. Knoll, O. Sharon, G.H. Posner, and N. Stern Vitamin D analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cells J. Steroid Biochem. Mol. Biol. 121 2010 265 267
10. L. Thompson, S. Wang, O. Tawfik, K. Tempelton, J. Tancabelic, D. Pinson, H.C. Anderson, J. Keighley, and R. Garimella Effect of 1α,25- dihydroxyvitamin D3 and 25-hydroxyvitamin D3 on proliferation, differentiation and apoptosis in human osteosarcoma cell lines Abst Proceeding of 14th vitamin D workshop Brugge, Belgium, October 2009
11. D. Sömjen, G.J. Sömjen, Y. Weisman, and I. Binderman Evidence for 24,25-dihydroxycholecalciferol receptors in long bones of newborn rats Biochem. J. 204 1982 31 36
12. 3 in hypertrophic cells J. Steroid Biochem. Mol. Biol. 121 2010 212 216
13. 3 (JKF) up regulates the induction of creatine kinase B by 17β estradiol in osteoblast-like ROS 17/2.8 cells and in rat diaphysis J. Steroid Biochem. Mol. Biol. 77 2001 205 212
14. D. Somjen, S. Katzburg, O. Sharon, A.M. Kaye, B. Gayer, F. Kohen, D. Hendel, and G.H. Posner Modulation of response to estrogens in human female bone cells by a non-calcemic vitamin D analog: changes in nuclear and membranal binding J. Steroid Biochem. Mol. Biol. 89-90 2004 393 395
15. D. Somjen, G.H. Posner, Y. Weisman, and A.M. Kaye Less- calcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in the rat skeletal tissues J. Endocrinol. Invest. 30 2007 91 96
16. D. Somjen, K. Tordjman, S. Katzburg, E. Knoll, O. Sharon, R. Limor, M. Naidich, Z. Naor, D. Hendel, and N. Stern Lipoxygenase metabolites are mediators of PTH-dependent human osteoblast growth Bone 42 2008 491 497
17. W.G. Tong, X.Z. Ding, and T.E. Adrian The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells Biochem. Biophys. Res. Commun. 296 2002 942 948
18. O. Tunc, J. Thompson, and K. Tremellen Development of the NBT assay as a marker of sperm oxidative stress Int. J. Androl. 33 2008 13 21
19. H.J. Kim, E.J. Chang, H.M. Kim, S.B. Lee, H.D. Kim, G. Su Kim, and H.H. Kim Antioxidant α-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-κB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-κB ligand and tumor necrosis factor-α Free Rad. Biol. Med. 40 2006 1483 1493
20. N. Mody, F. Parhami, T.A. Sarafian, and L.L. Demer Oxidative stress modulates osteoblastic differentiation of vascular and bone cells Free Rad. Biol. Med. 31 2001 509 519
21. R.F. Klein, J. Allard, Z. Avnur, T. Nikolcheva, D. Rotstein, A.S. Carlo, M. Shea, R.V. Waters, J.K. Belknap, G. Peltz, and E.S. Orwoll Regulation of bone mass in mice by the lipoxygenase gene ALOx15 Science 303 2004 229 232
22. S. Ichikawa, D.L. Koller, M.L. Johnson, D. Lai, X. Xuei, H.J. Edenberg, R.F. Klein, E.S. Orwoll, S.L. Hui, T.M. Foroud, M. Peacock, and M.J. Econs Human ALOX12, but not ALOX15, is associated with BMD in white men and women J. Bone Miner. Res. 21 2006 556 564